The novel μ-opioid receptor antagonist GSK1521498 decreases both alcohol seeking and drinking: evidence from a new preclinical model of alcohol seeking by Giuliano, Chiara et al.
The Novel μ-Opioid Receptor Antagonist GSK1521498
Decreases Both Alcohol Seeking and Drinking: Evidence
from a New Preclinical Model of Alcohol Seeking
Chiara Giuliano*,1, Charles R Goodlett2, Daina Economidou1, Maria P García-Pardo3, David Belin4,
Trevor W Robbins1, Edward T Bullmore1,5,6 and Barry J Everitt1
1Behavioral and Clinical Neuroscience Institute and Department of Psychology, University of Cambridge, Cambridge, UK; 2Department of
Psychology, Indiana University–Purdue University Indianapolis, Indianapolis, IN, USA; 3Unit of Research Psychobiology of Drug Dependence,
Department of Psychobiology, School of Psychology, University of Valencia, Valencia, Spain; 4Department of Pharmacology, University of Cambridge,
Cambridge, UK; 5Department of Psychiatry, University of Cambridge, Cambridge, UK; 6Clinical Unit Cambridge and Academic DPU,
GlaxoSmithKline R&D, Clinical Unit Cambridge, Addenbrooke’s Hospital, Cambridge, UK
Distinct environmental and conditioned stimuli influencing ethanol-associated appetitive and consummatory behaviors may jointly
contribute to alcohol addiction. To develop an effective translational animal model that illuminates this interaction, daily seeking responses,
maintained by alcohol-associated conditioned stimuli (CSs), need to be dissociated from alcohol drinking behavior. For this, we established
a procedure whereby alcohol seeking maintained by alcohol-associated CSs is followed by a period during which rats have the opportunity
to drink alcohol. This cue-controlled alcohol-seeking procedure was used to compare the effects of naltrexone and GSK1521498, a novel
selective μ-opioid receptor antagonist, on both voluntary alcohol-intake and alcohol-seeking behaviors. Rederived alcohol-preferring,
alcohol-nonpreferring, and high-alcohol-drinking replicate 1 line of rats (Indiana University) first received 18 sessions of 24 h home cage
access to 10% alcohol and water under a 2-bottle choice procedure. They were trained subsequently to respond instrumentally for access
to 15% alcohol under a second-order schedule of reinforcement, in which a prolonged period of alcohol-seeking behavior was maintained
by contingent presentations of an alcohol-associated CS acting as a conditioned reinforcer. This seeking period was terminated by 20 min
of free alcohol drinking access that achieved significant blood alcohol concentrations. The influence of pretreatment with either naltrexone
(0.1− 1− 3 mg/kg) or GSK1521498 (0.1–1–3 mg/kg) before instrumental sessions was measured on both seeking and drinking behaviors,
as well as on drinking in the 2-bottle choice procedure. Naltrexone and GSK1521498 dose-dependently reduced both cue-controlled
alcohol seeking and alcohol intake in the instrumental context as well as alcohol intake in the choice procedure. However, GSK1521498
showed significantly greater effectiveness than naltrexone, supporting its potential use for promoting abstinence and preventing relapse in
alcohol addiction.
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INTRODUCTION
Alcohol is the most commonly used addictive substance
worldwide, and alcohol use disorders place a major socio-
economic and public health burden on modern societies.
Some 17.6 million people are estimated to abuse alcohol in
United States (National Council on Alcoholism and Drug
Dependence), whereas 1.6 million people are addicted to
alcohol in the United Kingdom, where alcohol consump-
tion has increased by 9% over the past 3 decades (Alcohol
Concern, UK (http://www.alcoholconcern.org.uk/)). Des-
pite a major need, there are however few effective
pharmacological treatments for alcohol addiction, especially
those that promote abstinence and prevent relapse.
Preclinical research on alcohol addiction and associated
treatment development strategies have focused almost exclu-
sively on the factors determining the propensity to maintain
high levels of alcohol intake, reflecting the importance of
intoxication and neuroadaptive changes during protracted
withdrawal as the driving force to addiction (Koob, 2013).
The commonly used strains of laboratory rats do not readily
drink high quantities of alcohol unless sweet taste (eg,
sucrose) fading techniques are used to induce it (see, eg,
Samson, 1986; Czachowski and Samson, 2002), or animals
are exposed intermittently to alcohol for a prolonged period
of time under two- or three-bottle choice procedures (Wise,
1973; Simms et al, 2008; Carnicella et al, 2014), or are first
made dependent by exposing them for long periods to
alcohol in vapor chambers to induce drinking in withdrawal
(Koob, 2013).
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A complementary approach is to study rats that have,
through selective breeding strategies, a spontaneous propen-
sity to drink and prefer alcohol. Thus, alcohol-preferring (P)
and high-alcohol-drinking (HAD) lines have been estab-
lished on the basis of their preference for a 10% alcohol
solution over water and their consumption of 45 g of
alcohol/kg body weight/day. Both P and HAD lines have
been shown to drink ethanol under free-choice conditions
(McBride et al, 2014), to be highly motivated for ethanol
compared with alcohol-nonpreferring (NP) rats, and to
readily acquire instrumental responding for ethanol
(Czachowski and Samson, 2002).
However, although alcohol drinking to intoxication is the
major behavioral characteristic of those addicted to alcohol,
such individuals also crave alcoholic beverages and spend
time actively seeking alcohol, as well as drinking compul-
sively. Effective treatments for alcoholism may therefore not
only be those reducing volumes drunk, such as the recently
approved nalmefene (Gual et al, 2014), but may also be those
that can reduce the craving and alcohol seeking that leads to
drinking.
Alcohol-associated conditioned stimuli are known to elicit
craving in alcohol-dependent individuals and cue-reactivity
procedures have been used to identify relapse prevention
treatments (Niaura et al, 1988). The invigorating impact
of drug-associated conditioned stimuli (CSs) on seeking
behavior has been operationalized in models of CS-induced
relapse (Ciccocioppo et al, 2002; Gipson et al, 2013; Lee et al,
2006; Marchant et al, 2013) as well as cue-controlled cocaine-
or heroin-seeking behavior (Arroyo et al, 1998; Economidou
et al, 2011; Giuliano et al, 2013) and CS-dependent seeking of
high incentive foods that is associated with obesity and binge
eating (Giuliano et al, 2012). Although outbred rat strains
will respond instrumentally for alcohol (Augier et al, 2014),
and alcohol-associated CSs can elicit approach (Tomie and
Sharma, 2014) and serve as conditioned reinforcers (Smith
et al, 1977; Panlilio et al, 2004; Milton et al, 2012; Rodd et al,
2004), attempts to establish vigorous CS-dependent alcohol
seeking that mediates delays to the opportunity to drink have
proven difficult, probably because alcohol is an apparently
weak reinforcer for rats with little or no propensity to drink.
Here we established a procedure in which P, and HAD rats
seek alcohol for prolonged periods of time during which the
response-contingent presentation of an alcohol-associated
CS would bridge delays before animals eventually earned the
opportunity freely to drink alcohol for 20 min (to ‘drink at
the bar’).
Having established this novel CS-controlled alcohol-
seeking and drinking procedure, we then investigated the
effects of a novel, putative treatment for alcohol dependence,
GSK1521498. We further compared its effects with those of a
clinically approved treatment for alcoholism, naltrexone, that
has previously been shown to reduce ethanol drinking
(Davidson and Amit, 1997; Froehlich et al, 1990; Henderson-
Redmond and Czachowski, 2014) and cue-induced reinstate-
ment (Ciccocioppo et al, 2002) in animal models, as well as
to decrease cue-induced craving in human alcohol abusers
(Rohsenow et al, 2000). Both compounds target the μ-opioid
receptors (MORs), but GSK1521498 is a more selective MOR
antagonist than naltrexone, and unlike naltrexone, has no
partial agonist activity (Nathan et al, 2012; Kelly et al, 2014)
and instead has, in some in vitro assays, minor inverse
agonist activity (Ignar et al, 2011; Kelly et al, 2014). The
effects of both treatments on CS-controlled alcohol-seeking
behavior, alcohol intake during the free-access period earned
by rats through making seeking responses, as well as in a
home environment two-bottle choice procedure, were
investigated.
MATERIALS AND METHODS
Animals
Male rederived rP (~30 days old, n= 63), rNP (n= 20), and
rHAD1 rats (n= 20) were obtained from Indiana University
Medical Center (Indiana). See Supplementary Information.
Rats from the first and the second cohorts were divided
into two subgroups: some were exposed to alcohol in a
two-bottle choice procedure (EtOH-experienced), whereas
others were screened first for anxiety-like behavior and left in
their home cages for the same period of time (EtOH-naive).
All rats then began instrumental training at the same time.
rP and rNP rats from the second cohort were first tested on
the elevated plus maze (EPM) before undergoing instru-
mental training and pharmacological treatments under the
second-order schedule of reinforcement for 15% EtOH to
assess effects on alcohol-seeking behavior. The EPM tested
the anxiety-like phenotype previously, but variably, shown
in P rats (Stewart et al, 1993). Finally, rHAD1 rats from the
second cohort and rP rats from the third cohort underwent
pharmacological manipulations on the two-bottle choice
procedure (Table 1a).
Alcohol Consumption: Two-Bottle Choice Procedure
Animals were presented with either continuous or inter-
mittent concurrent access (depending on the cohort of
animals, see Table 1a) to 10% EtOH (v/v) and water in their
home cage for a total of 18 sessions. Voluntary consumption
was assessed every 24 h. See Supplementary Information.
Elevated Plus Maze
EtOH-naive animals were assessed for anxiety on the EPM as
previously described (Dilleen et al, 2012). See Supplementary
Information.
Alcohol Consumption: Instrumental Conditioning
Apparatus. Behavioral training was conducted in operant
chambers as previously described (Giuliano et al, 2013). See
Supplementary Information.
Alcohol seeking: second-order schedule of reinforcement for
15% EtOH. Rats were water-deprived for 22 h/day during
the first 5 days of training that consisted of the following
4 phases.
i. Rats were initially trained to associate a light stimulus
presentation with access to drinking EtOH (5 daily
sessions): 1 min CS was illuminated during 1 min free
access to a bottle containing 15% EtOH (v/v) in the
operant chamber (Pavlovian conditioning) under a Ran-
dom Time 60-s procedure. The rats received in average 38
CS-alcohol pairings in each 45 min session.
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ii. Rats were then trained to press a lever under a fixed-ratio 1
schedule (FR1) to have free access to 15% EtOH: each
active lever press resulted in 20 s CS illumination above
the active lever, retraction of both levers, free access to a
15% EtOH bottle and 20 s turning off of the house light.
After these 20 s, the house light was again illuminated,
the alcohol-associated CS was turned off, and the two levers
again inserted into the chamber. Rats were limited to a
maximum of 45 rewards/2 h session. Following acquisition
of EtOH self-administration (7 daily sessions), a fixed-
interval schedule (FI) of reinforcement was introduced.
iii. The FI increased daily from 1min to 2–4–6–8–10 min,
before stabilizing at FI15 min for 3 consecutive sessions
(total 9 daily sessions). The end of each FI was associated
with a progressively longer drinking period of CS-paired
free access to 15% EtOH: from 1min under FI1 to 20 min
under FI15.
iv. Subsequently, a second-order schedule of reinforcement
was introduced, in which every tenth active lever press
during one FI15 resulted in a 1 s CS presentation (FI15
(FR10:S)). At the end of FI15, rats earned 20 min of
CS-paired free access to 15% EtOH in the operant
chamber (minimum 25 daily sessions). Representative
values of blood alcohol concentrations (BACs) following
the 20 min free access to 15% EtOH were measured. See
Supplementary Information.
After alcohol-seeking behavior had been acquired, depen-
dence of seeking responses on contingent presentations of the
alcohol-associated CS was assessed by omitting the CS in some
sessions. As completion of each FR10 in these CS omission
sessions had no consequence (in terms of CS presentation),
these were effectively simple FI15min sessions, as earlier in
training. The CS omission sessions were followed by additional
sessions in which the 1 s CS presentations were again
contingent on completion of each FR10, that is, the FI15
(FR10:S) second-order schedule was reinstated.
Drugs
EtOH solutions were prepared by mixing 99.8% EtOH
(Sigma, UK) in tap water to obtain 10% EtOH (v/v; 2-bottle
Table 1 (a) Schematic Representation of the Experimental Design. (b) Summary of Alcohol Intakes under Two-Bottle Choice Procedure
In (a), rats from three different cohorts were used. Those from the first and the second cohorts were divided into two subgroups: some were exposed to alcohol in a
two-bottle choice procedure (EtOH-experienced), whereas others stayed in their home cage for the same period of time (EtOH-naive). All rats started the instrumental
training at the same time. rP and rNP rats from the second cohort were tested on the EPM, before undergoing the instrumental training and pharmacological
manipulations on the seeking behavior under the second-order schedule of reinforcement for 15% EtOH. Finally, rHAD1 rats from the second cohort and rP rats from
the third cohort underwent pharmacological manipulations on the two-bottle choice procedure.
In (b), average alcohol intakes (g/kg) and alcohol preferences over the total fluid intake/24 h (%) from the last 3 of the 18 sessions of 2-bottle choice procedure in the
several cohorts of animals tested are shown: the first cohort consisted of rP rats, the second cohort consisted of rP, rNP, and rHAD1 rats, and the third cohort consisted
of additional rP rats. The data are expressed as mean± SEM.
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choice procedure) or 15% EtOH (v/v; instrumental
conditioning).
Naltrexone (Sigma, UK) and GSK1521498 (GlaxoSmithK-
line, UK) were prepared freshly on each test day following
the protocol previously described (Giuliano et al, 2012,
2013). See Supplementary Information.
Statistical Analysis
Data were analyzed using repeated measures ANOVA (SPSS
21) with time, schedule, or dose as within-subject factors.
Two-tailed values of P≤ 0.05 were considered statistically
significant. Significant main effects and interactions were
analyzed further using Dunnett’s post hoc test where
appropriate. See Supplementary Information.
RESULTS
Alcohol Consumption: Two-Bottle Choice Procedure
When given free choice between 10% EtOH and water, rP
and rHAD1, but not rNP, rats displayed a high propensity
to drink alcohol and readily developed a marked preference
for alcohol. Average intakes from the last 3 of the 18 total
sessions in animals from all the cohorts used are presented in
Table 1b. Alcohol intakes and preferences over 18 sessions in
animals from the first and the second cohorts are presented
in Figure 1a and b and Figure 2a and b, respectively.
rP rats Are More Anxious Than rNP Rats on the EPM
EtOH-naive rP rats showed more anxiety-like behavior
(ie, more time in the open arms) on the EPM relative to
EtOH-naive rNP rats (Figure 2a and d). See Supplementary
Information.
Cue-Controlled Alcohol-Seeking Behavior under a
Second-Order Schedule of 15% EtOH Reinforcement
First cohort. rP rats were divided into two subgroups
before being trained in the cue-controlled alcohol-seeking
task: (1) rP EtOH-experienced rats, exposed to 10% EtOH
under the 2-bottle choice procedure; (2) rP EtOH-naive rats,
screened first for anxiety-like behavior and left in the home
cage for the same period of time on ad libitum food and
water. All the animals then underwent instrumental seeking
training (Table 1a).
The rP EtOH-experienced rats trained instrumentally to
seek 15% EtOH under FI15 made 42± 2.87 lever presses in
the 15 min alcohol-free period (Figure 1c), whereas EtOH-
naive rats displayed 29± 2.38 alcohol-seeking responses in
the same 15 min alcohol-free period (Figure 1d). When the
brief 1 s CS presentation contingent on lever pressing was
introduced (ie, a second-order schedule (FI15(FR10:S))), the
alcohol-seeking lever presses during the 15 min alcohol-free
period increased in EtOH-experienced and EtOH-naive rats
to 126± 13.65 (Figure 1c) and 104± 17.91 (Figure 1d),
respectively, during the last 3 of 12 sessions of training
(Po0.001 vs FI15). A further 8 sessions in which the CS was
omitted (in EtOH-experienced subjects only) resulted in a
marked decrease in seeking responses during the 15 min
alcohol-unaffected interval to 65± 4.37 lever presses during
the seventh and eighth sessions (Po0.01 vs (FI15(FR10:S))
(Figure 1c). This demonstrates that the vigorous alcohol-
seeking behavior of EtOH-experienced rats depended on
contingent presentations of the alcohol-associated CS. This
control over alcohol seeking by alcohol-associated CSs was
further confirmed by the reestablishment of high levels of
seeking responses (105± 13.06 lever presses in 15 min
(Po0.05 vs FI15 and P=NS vs (FI15(FR10:S)) on subse-
quent reintroduction of contingent presentations of the CS in
8 additional sessions ((FI15(FR10:S)); overall schedule effect
(F(3, 39)= 27.48; Po0.001); Figure 1c).
At the end of the alcohol-unaffected seeking interval,
under either FI15 or (FI15(FR10:S)), rP rats had earned
20 min free-drinking access to 15% EtOH in the operant
chamber. EtOH-experienced and EtOH-naive rats consumed
1.62± 0.16 g/kg (Figure 1e) and 1.09± 0.13 g/kg (Figure 1f)
of alcohol, respectively, under the FI15 schedule of
reinforcement (ie, when no CS was presented). Their intake
in the 20 min following seeking when CSs were presented
was 1.54± 0.15 g/kg (Figure 1e) and 0.99± 0.09 g/kg
(Figure 1f), respectively (EtOH exposure: (F(1, 32)= 20.35;
Po0.001); schedule × time × EtOH exposure: (F(2, 64)= 4.34;
Po0.05); no effect of schedule).
Second cohort. rP and rNP (but not rHAD1) rats were
divided into two subgroups based on their EtOH experience
(Table 1a).
rP rats. After concurrent access to 10% EtOH and water
for 18 consecutive days in the home cage (Figure 2a and b),
rP EtOH-experienced and rP EtOH-naive rats trained instru-
mentally to seek 15% EtOH under FI15 made respectively
44± 6.51 (Figure 2e) and 41± 5.78 (Figure 2f) lever presses
in 15 min. When the brief 1 s CS presentation contingent
on lever pressing was introduced, EtOH-experienced and
EtOH-naive rats increased their lever presses to 96± 13.25
(Figure 2e) and 98± 13.67 (Figure 2f), respectively, in 15 min
after 12 sessions of training (schedule × time interaction
(F(2, 36)= 11.91; Po0.001; no effect of EtOH exposure).
Alcohol intake in the 20 min free-access period under either
FI15 or (FI15(FR10:S)) was respectively 0.60± 0.06 and
0.70± 0.06 g/kg in EtOH-experienced rats (Figure 2g), and it
was respectively 0.59± 0.07 and 0.63± 0.09 g/kg in EtOH-
naive rats (Figure 2h) (no effect of schedule or time).
rNP rats. In marked contrast to rP rats, rNP EtOH-
experienced and rNP EtOH-naive rats made respectively
only 9± 1.97 (Figure 2e) and 14± 2.75 (Figure 2f) active lever
presses in 15 min under FI15. They only increased their
responding to respectively 16± 4.45 (Figure 2e) and 28± 7.62
(Figure 2f) when the alcohol-associated CS was introduced
response contingently (schedule effect (F(1, 8)= 3.35; NS)).
Alcohol intake was very low under both schedules, reaching
0.18± 0.05 g/kg under FI15 and 0.17± 0.06 under (FI15
(FR10:S)) in rNP EtOH-experienced rats (Figure 2g) and
0.21± 0.05 g/kg under FI15 and 0.15± 0.05 under (FI15
(FR10:S)) in rNP EtOH-naive rats (Figure 2h).
rHAD1 rats. Under FI15, rHAD1 rats made 19± 3.63
active lever presses (Figure 2e) and drank 0.76± 0.09 g/kg of
EtOH (Figure 2g) in the following 20 min drinking period.
Cue-maintained alcohol seeking and μ-opioid receptors
C Giuliano et al
2984
Neuropsychopharmacology
Once the response-contingent alcohol CS was introduced
((FI15(FR10:S))), active lever presses increased to 47± 6.05
(Figure 2e), with an alcohol intake of 0.74± 0.07 g/kg in the
following 20 min (Figure 2g). Their seeking performance was
significantly lower than rP rats, despite similar EtOH intake
during the 20 min of earned free access (main effect of line (F
(1, 18)= 10.59; Po0.01); time × schedule × line interaction (F
(2, 36)= 5.60; Po0.01); no differences in EtOH intake (F
(1, 18)= 1.26; NS).
During the 20 min period of free access to 15% EtOH in
the operant chamber after CS-controlled seeking, the rP and
rHAD1 rats consumed rather large amounts of alcohol,
reaching BACs in the range 15–79 mg% and 11–85 mg%,
respectively, that were correlated with the amount of alcohol
drunk during 20 min (R= 0.52, Po0.05 and R= 0.82,
Po0.01 for rP and rHAD1 rats, respectively).
Pharmacological Manipulations
GSK1521498 decreased both cue-controlled alcohol seeking
and alcohol drinking
rP rats. GSK1521498 dose-dependently decreased seek-
ing behavior (rP EtOH-experienced (F(3, 27)= 20.98;
Po0.001, partial effect size= 0.70); Figure 3a; rP-naive
(F(3, 27)= 27.60; Po0.001, partial effect size= 0.75);
Figure 3b), and alcohol intake during the 20 min free-
drinking period (rP EtOH-experienced (F(3, 27)= 33.72;
Po0.001, partial effect size= 0.79); Figure 3c); rP-naive
Figure 1 Voluntary alcohol intake, instrumental conditioning, and alcohol-seeking characterization in rP rats (first cohort). Rats from the first cohort were
divided into two subgroups: some were exposed to alcohol in a two-bottle choice procedure (EtOH-experienced, on the left), whereas others stayed in their
home cage for the same period of time (EtOH-naive, on the right). (a) The 10% alcohol intake (g/kg) and (b) percentage of alcohol preference over the total
fluid intake (%) were assessed in rP (n= 20) rats every 24 h using the 2-bottle choice procedure for 18 continuous days. All the animals (EtOH-experienced
and EtOH-naive) were then instrumentally trained to seek 15% EtOH. Lever presses (mean± SEM) under FI15 (white bars) and under second-order schedule
of reinforcement (diagonal bars) are shown in (c) and (d). Further 8 sessions, in which the CS was omitted (gray bars), were delivered to EtOH-experienced
rats to assess the role of the CS as a conditioned reinforcer. Additional 8 sessions under second-order schedule of reinforcement were then delivered to
reestablish CS-maintained seeking behavior (c). The acquisition of ethanol-seeking behavior in rats with no previous history of ethanol exposure was similar to
that of EtOH-experienced rats (schedule × time× EtOH experience interaction (F(2, 64)= 1.31; NS); EtOH experience effect (F(1, 32)= 1.97; NS)). Alcohol
intake (g/kg) during the 20 min drinking period earned by responding during the FI15 schedule (white bars) and the second-order schedule of reinforcement
(diagonal bars) are shown in (e) and (f). EtOH intake in rP EtOH-naive rats was overall less than in rP EtOH-experienced rats (schedule × time× EtOH
exposure interaction (F(2, 26)= 4.34; Po0.05); EtOH experience effect (F(1, 32)= 20.35; Po0.001)).
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(F(3, 27)= 29.65; Po0.001, partial effect size= 0.77);
Figure 3d).
rNP rats. GSK1521498 affected neither seeking behavior
(F(3, 24)= 1.91; NS, partial effect size= 0.19; Figure 3a) nor
alcohol intake (F(3, 24)= 2.32; NS, partial effect size= 0.22)
in rNP EtOH-experienced rats (Figure 3c), but reduced the
seeking behavior (F(3, 27)= 7.70; Po0.01, partial effect
size= 0.46; Figure 3b) and alcohol intake (F(3, 27)= 9.28;
Po0.01, partial effect size= 0.51) in rNP-naive rats
(Figure 3d).
rHAD1 rats. GSK1521498 reduced both seeking beha-
vior (F(3, 24)= 17.21; Po0.001, partial effect size= 0.68;
Figure 3a) and alcohol intake (F(3, 24)= 13.85; Po0.001,
partial effect size= 0.63; Figure 3c).
Figure 2 Voluntary alcohol intake, instrumental conditioning, and alcohol-seeking characterization in rP, rNP, and rHAD1 rats (second cohort). Rats from
the second cohort were divided into two subgroups: some were exposed to alcohol in a 2-bottle choice procedure (EtOH-experienced, on the left), whereas
others were screened for anxiety-like profile and stayed in their home cage for the same period of time (EtOH-naive, on the right). (a) The 10% alcohol intake
(g/kg) and (b) percentage of alcohol preference over the total fluid intake (%) were assessed every 24 h using the 2-bottle choice procedure for 18 continuous
days in rP (n= 20), rNP (n= 10), and rHAD1 (n= 18) EtOH-experienced rats. In the meantime, EtOH-naive rats (n= 10 rP rats; n= 10 rNP rats) were
assessed for anxiety-like behavior on the EPM. The % of time spent in the open arms (% time OA/(OA+CA), mean± SEM) and % of open arm entries
(% entries OA/(OA+CA), mean± SEM) are shown in (c) and (d), respectively. All the animals (EtOH-experienced and EtOH-naive) were then instrumentally
trained to seek 15% EtOH. Lever presses (mean± SEM) under FI15 (white bars) and under second-order schedule of reinforcement (diagonal bars) are
shown in (e) and (f) in EtOH-experienced and EtOH-naive rats, respectively. Alcohol intake (g/kg) during the 20 min drinking period earned by responding
during the FI15 schedule (white bars) and the second-order schedule of reinforcement (diagonal bars) are shown in (g) and (h) in EtOH-experienced and
EtOH-naive rats, respectively. EtOH-naive rP rats were no different to EtOH-experienced rats in their acquisition of alcohol seeking (schedule × time× EtOH
experience interaction (F(2, 36)= 0.41; NS); EtOH experience effect (F(1, 18)= 0.03; NS)).
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Naltrexone Decreased Both Cue-Controlled Alcohol
Seeking and Alcohol Drinking
rP rats. Naltrexone reduced alcohol-seeking behavior (rP
EtOH-experienced (F(3, 27)= 9.02; Po0.01, partial effect
size= 0.50; Figure 3e; rP EtOH-naive (F(3, 27)= 15.81;
Po0.001, partial effect size= 0.64; Figure 3f) and the 15%
EtOH intake during the 20 min drinking period (rP EtOH-
experienced (F(3, 27)= 29.63; Po0.001, partial effect size=
0.77; Figure 3g; rP EtOH-naive (F(3, 27)= 45.69; Po0.001,
partial effect size= 0.83; Figure 3h).
rNP rats. Naltrexone reduced the low level of seeking
behavior of rNP rats (rNP EtOH-experienced (F(3, 24)=
3.95; P= 0.05, partial effect size= 0.33; Figure 3e; rNP-naive
(F(3, 27)= 5.28; Po0.05, partial effect size= 0.37; Figure 3f)
Figure 3 GSK1521498 and naltrexone decreased EtOH seeking and voluntary consumption. Effects of GSK1521498 (first and second rows) and effects of
naltrexone (third and fourth rows) on alcohol seeking and taking under a second-order schedule of reinforcement in EtOH-experienced rats (n= 10 rP, n= 9
rNP, n= 9 rHAD1), on the left, and in EtOH-naive rats (n= 10 rP, n= 9 rNP), on the right, are shown. Number of active lever presses (a, b, e, f) and alcohol
intake (g/kg) during the 20 min drinking period earned by responding for alcohol-associated CS presentation (c, d, g, h) are presented. Both GSK1521498 and
naltrexone significantly reduced seeking behavior and alcohol drinking in rP rats regardless of their alcohol-experience (naltrexone: dose × alcohol experience
(F(3, 57)= 0.27; NS); GSK1521498: dose × alcohol experience (F(3, 54)= 0.69; NS)). The data are expressed as mean± SEM. *Po0.05, **Po0.01, and
***Po0.001 compared with vehicle-treated animals.
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and the low level of alcohol intake (rNP EtOH-experienced
(F(3, 24)= 5.08; Po0.05, partial effect size= 0.39; Figure 3g;
rNP-naive (F(3, 27)= 8.50; Po0.01, partial effect size= 0.48;
Figure 3h), but post -hoc pairwise comparisons revealed no
effect of dose in rNP EtOH-experienced rats.
rHAD1 rats. Naltrexone reduced both EtOH seeking
(F(3, 24)= 5.67; Po0.05, partial effect size= 0.79;
Figure 3e) and alcohol intake (F(3, 24)= 18.26; Po0.001,
partial effect size= 0.69; Figure 3g).
GSK1521498 Decreased the Consumption of EtOH in the
Two-Bottle Choice Procedure
rP and rHAD1 rats. GSK1521498 was tested on EtOH
consumption in the intermittent access two-bottle choice
procedure at 30 min and 1–2–4–6–12–24 h after the begin-
ning of the access period (30 min after GSK1521498 treat-
ment). GSK1521498 dose-dependently reduced 10% EtOH
intake during the 24 h alcohol vs water access (rP:
(F(18, 396)= 32.61; Po0.001, partial effect size for dose=
0.77, partial effect size for dose × time= 0.60; Figure 4a
and b; rHAD1: (F(18, 342)= 42.02; Po0.001, partial effect
size for dose= 0.77, partial effect size for dose × time= 0.69;
Figures 4e and f). See Supplementary Information.
Naltrexone Decreased the Consumption of EtOH in the
Two-Bottle Choice Procedure
rP and rHAD1 rats. The effects of naltrexone on EtOH
consumption were investigated at 30 min and 1–2–4–6–12–
24 h after the beginning of the access period (10 min after
naltrexone SC injection). Naltrexone dose-dependently
decreased 10% EtOH intake during the 24 h alcohol vs water
access (rP: treatment × time (F(18, 396)= 3.88; Po0.001,
partial effect size for dose × time= 0.63; Figures 4c and d;
rHAD1: treatment (F(3, 57)= 14.90; Po0.001, partial effect
size= 0.44), time (F(6, 114)= 550.61; Po0.001, partial
effect size= 0.97), treatment × time (F(18, 342)= 1.45; NS;
Figures 4g and h). See Supplementary Information.
DISCUSSION
Alcohol-preferring, but not alcohol-nonpreferring, rats were
shown to acquire high levels of CS-controlled alcohol-
seeking behavior for 15% EtOH and to achieve blood alcohol
concentrations up to 80 mg% in the immediately following
20 min earned drinking periods. Selective antagonism at the
MOR by the novel compound GSK1521498 markedly
reduced both cue-controlled alcohol seeking and alcohol
drinking, effects that were both greater and longer lasting
than those of naltrexone.
Cue-Controlled Alcohol-Seeking Behavioral Procedure
Alcohol-related cues, including the sight and smell of alcohol
drinks, acquire conditioned incentive properties (Barker and
Taylor, 2014; Field and Duka, 2002), can provoke intense
craving in individuals that abuse or have lost control
over alcohol (Ludwig, 1986; De Bruijn et al, 2004), and
may be a predictor of relapse after abstinence (Schneekloth
et al, 2012).
The first aim of this study, then, was to develop a
procedure to quantify CS-controlled alcohol seeking over
protracted periods of time in rats selectively bred for the
propensity to drink alcohol. This was achieved by training
rats daily to seek alcohol such that instrumental responding
was under the control of alcohol-associated CSs that
mediated delays to drinking and alcohol reinforcement by
acting as conditioned reinforcers. This novel procedure
therefore differs from extinction–reinstatement tasks by
measuring the daily propensity for CS-elicited and main-
tained alcohol seeking and drinking that was only seen in
rats predisposed to drink, rather than the reinstatement of
instrumental responding after extinction that provides a low
response baseline from which to measure CS effects on
reinstatement (generally assumed to be a measure of relapse),
but without the opportunity to drink (Marchant et al, 2013).
Even though a CS–alcohol Pavlovian association can be
established in rats not genetically predisposed voluntarily
to drink alcohol and this alcohol-associated CS can elicit
approach (Tomie and Sharma, 2014), support Pavlovian-
to-instrumental transfer (Milton et al, 2012), and act as a
conditioned reinforcer (Samson et al, 2001; Milton et al,
2012), the present data show that an alcohol-associated CS
cannot sustain prolonged and vigorous periods of alcohol-
seeking behavior in animals not predisposed to drink alcohol
(ie, in the NP selected line).
The rederived P, NP, and HAD rats used here have been
bred over many generations as a rodent model to investigate
the genetic basis of excessive alcohol consumption by
humans (Czachowski and Samson, 2002; McBride et al,
2014). These lines have been both behaviorally and
neurobiologically characterized and show phenotypic differ-
ences in their responses to ethanol that may be of relevance
to the neurogenetic mechanisms underlying ethanol pre-
ference or nonpreference (McBride et al, 2014). For example,
P rats have a lesser aversive response to ethanol in a
conditioned taste aversion procedure (Froehlich et al, 1988)
and may show more anxiety-like behavior in an EPM
compared with NP rats (Stewart et al, 1993), the latter
observation being confirmed in the rP cohorts studied here,
although this high-anxiety phenotype is not always observed
(Viglinskaya et al, 1995).
In the present study we established an alcohol-seeking
procedure in alcohol-preferring rats by adapting the second-
order schedule of reinforcement used previously to study not
only cocaine and heroin seeking (Arroyo et al, 1998;
Schindler et al, 1988; Everitt and Robbins, 2000; Giuliano
et al, 2013), but also the seeking of high incentive foods
(Giuliano et al, 2012) or sexual rewards (Everitt, 1990), in
which seeking was measured before unrestrained access to,
and consummatory interaction, with these rewards. Simi-
larly, here rats were trained to make instrumental seeking
responses over 15 min in order to have access to alcohol for
an unrestricted 20 min drinking period in each daily session.
The rats were never food deprived, nor did they undergo
either sucrose fading or prior induction of dependence.
Alcohol seeking was markedly dependent on response-
contingent presentations of the alcohol-associated CS, as it
decreased following CS omission and increased to pre-CS-
omission levels following its reintroduction. This effect of CS
omission is key evidence that seeking behavior depends on
brief presentations of the CS that probably has conditioned
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reinforcing properties (Goldberg et al, 1981; Everitt and
Robbins, 2000). It is well established that response-con-
tingent, brief presentations of a CS paired with a drug reward
results in significantly greater control over second-order
responding than presentation of CSs explicitly not paired
with drug, further supporting the conditioned reinforcement
account (Goldberg et al, 1979). A related approach—that is, a
period of instrumental responding followed by free alcohol
drinking—has been used previously (Samson et al, 1999,
2001; Czachowski and Samson, 2002; Henderson-Redmond
and Czachowski, 2014), in which seeking behavior measured
over repeated extinction sessions (Czachowski and Samson,
1999) was suggested to be elicited by the Pavlovian context
in which the rats had been trained (Conklin et al, 2008). In
contrast, in the present experiments rats were always trained
in the same alcohol-associated context, but the addition
of response-contingent CS presentations resulted in more
vigorous and sustained seeking responses that were
Figure 4 GSK1521498 and naltrexone decreased EtOH intake in the two-bottle choice procedure. (On the top) Effects of GSK1521498 (first row, a, b)
and naltrexone (second row, c, d) on alcohol (a, c) and water (b, d) intake in the two-bottle choice procedure in rP rats (n= 23). (On the bottom) Effects of
GSK1521498 (third row, e, f) and naltrexone (fourth row, g, h) on alcohol (e, g) and water (f, h) intake in the two-bottle choice procedure in rHAD1 rats
(n= 23). Alcohol and water intake were assessed at different time points: 30 min and 1, 2, 4, 6, 12, and 24 h after the beginning of the access period, and 30 or
10 min after GSK1521498 or naltrexone treatment, respectively. The data are expressed as mean± SEM. *Po0.05, **Po0.01, and ***Po0.001 compared
with vehicle-treated animals at each time point, following repeated measures ANOVA per time point.
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maintained during repeated test sessions and always
terminated by the attainment of an alcohol free-drinking
period (ie, the animals were not under extinction condi-
tions), thereby also making a clear distinction between
appetitive and consummatory behavior (Czachowski and
Samson, 2002; Kaminski et al, 2008; Samson et al, 2001).
Two cohorts of rP and rNP rats were trained to respond
for 15% EtOH under cue-controlled seeking procedure either
after having been allowed previously to drink 10% EtOH in
a 2-bottle choice procedure, which confirmed the alcohol-
preferring phenotype, or without such experience and there-
fore being EtOH naive at the time of instrumental training.
Their seeking performance was very similar regardless of
their alcohol-drinking history.
We also studied a cohort of rHAD1 rats following
confirmation of their high alcohol-drinking phenotype in
the 2-bottle choice procedure with 10% EtOH. They showed
on initial exposure a higher level of ethanol intake than the
rP rats, confirming previous findings (Czachowski and
Samson, 2002), however, both lines subsequently showed
similar levels of ethanol consumption (~1 g/kg/20 min)
during the 20 min drinking period following CS-seeking
behavior. However, rP rats that tended to drink less ethanol
than rHAD1 rats in our studies, nevertheless responded
more for the opportunity to drink. This observation is
consistent with previous findings that P rats emit more
appetitive lever press responding under ratio schedules than
HAD rats (Czachowski and Samson, 2002). P rats have also
been reported to show more activity in locomotor chambers
and greater responsivity to a novel odor compared with
HAD rats (Nowak et al, 2000), perhaps indicating that P rats
display greater exploratory behavior or novelty seeking.
Effects of Manipulating the Opioid System on Alcohol
Seeking and Drinking
Having established this novel cue-controlled alcohol-seeking
and drinking procedure in alcohol-preferring rats, we
investigated the effects on both appetitive and consumma-
tory behavior of manipulating MOR activity. A large body of
evidence indicates that alcohol, as well as other rewarding
stimuli, may enhance the activity of the endogenous opioid
system (Herz, 1997) and MOR levels (Krishnan-Sarin et al,
1998). Moreover, MOR antagonists can decrease drinking in
individuals that abuse alcohol (Volpicelli et al, 1992; Drobes
et al, 2003) and alcohol craving in the presence of alcohol-
associated CSs (Monti et al, 1999).
Initially we investigated the effects of naltrexone on
alcohol drinking in the two-bottle choice procedure as well
as on CS-dependent alcohol seeking and on ethanol intake
in the free drinking sessions earned by making seeking
responses. As expected (Froehlich et al, 1990), pretreatment
with naltrexone dose-dependently reduced voluntary alcohol
intake in both two-bottle choice procedure and the instru-
mental context, but it also decreased alcohol-seeking
responses (see also Czachowski and Delory, 2009;
Henderson-Redmond and Czachowski, 2014). However,
although used to treat alcoholism (Volpicelli et al, 1992),
naltrexone is not universally viewed as an effective medica-
tion (Rösner et al, 2010) and the recent introduction of
nalmefene has been to reduce the volume of alcohol
consumed, rather than to maintain abstinence.
We have previously shown significantly greater effects of
the novel MOR antagonist GSK1521498, developed for
overeating and substance dependence disorders (Nathan
et al, 2012), over naltrexone in reducing highly palatable
food-, cocaine-, and heroin-seeking behavior in rats
(Giuliano et al, 2012, 2013), but it has no effect on locomotor
activity (Supplementary Figure S1). Treatment with
GSK1521498 dose-dependently reduced alcohol-seeking be-
havior and voluntary alcohol consumption in rP and rHAD1
rats more effectively than naltrexone and with a longer
duration of effect significantly, reflecting its longer half-life.
This apparently greater effectiveness of GSK1521498 is also
convergent with prior results and is possibly because of the
higher selectivity for the MOR (14–20-fold greater over δ-
and κ-opioid receptors compared with 4–10-fold selectivity
reported for naltrexone) or the 100-fold selectivity for MOR
over nociceptin/orphanin receptors (Ignar et al, 2011; Kelly
et al, 2014). Moreover, its more complete antagonist profile,
and its lesser inverse agonist activity under some assay
conditions, compared with the incomplete antagonism and
partial agonist activity of naltrexone, also possibly contribute
to the different behavioral profile of GSK1521498 (Ignar
et al, 2011; Kelly et al, 2014).
Clinical Implications
In humans, GSK1521498 has been shown generally to be well
tolerated compared with placebo, with no detectable dele-
terious effects on anxiety, mood, or other aspects of hedonic
function, or on liver or other blood safety parameters.
Importantly, its coadministration with ethanol did not affect
its tolerability (Ziauddeen et al, 2013b).
That GSK1521498 treatment reduces the tendency to seek
cocaine, heroin, high incentive chocolate, and, from the
present results, also alcohol in rats with a propensity to
drink, suggests effects on a common conditioned incentive
motivational system, in addition to its effects to reduce the
hedonic impact of the taste of chocolate and alcohol and
hence reduce ingestion. In humans, GSK1521498 also
reduced attentional bias to food-related stimuli in obese
binge eaters, for whom the food cues had higher motiva-
tional value (Ziauddeen et al, 2013a). However, GSK1521498
did not reduce the attentional bias to alcohol-related cues in
healthy social drinkers, for whom the motivational proper-
ties of alcohol cues may have been low (Ziauddeen et al,
2013b). Together, these observations suggest an important
specificity in the behavioral effects of GSK1521498 in
individuals having lost control over specific drugs or
ingestive rewards. In addition, the present data suggest that
administering GSK1521498 in an appropriate therapeutic
context should decrease the propensity of alcohol-dependent
patients, including those wanting to maintain abstinence, to
seek or crave alcoholic drinks, especially when elicited by
alcohol cues such as those in advertisements for drink
products. It may also reduce the volume of alcohol consumed
by patients seeking harm reduction treatments, as well as
patients relapsing from abstinence. Thus, the novel beha-
vioral procedure we have developed for evaluating alcohol
seeking and consumption in rats can generate therapeutic
predictions that may be important in guiding the clinical
development of GSK1521498 as a new treatment for alcohol
dependence.
Cue-maintained alcohol seeking and μ-opioid receptors
C Giuliano et al
2990
Neuropsychopharmacology
FUNDING AND DISCLOSURE
TWR has consulted for GSK, Cambridge Cognition, Lilly,
Lundbeck, and Merck. He also has research grants with GSK,
Lilly, and Lundbeck. ETB is employed half-time by the
University of Cambridge and half-time by GSK; he holds
stock in GSK. CG, CRG, DE, MPG-P, DB, and BJE declare
no conflict of interest.
ACKNOWLEDGMENTS
This study was funded by Medical Research Council
Programme Grant (no. G1002231) and by GlaxoSmithKline
(GSK) that has a commercial interest in GSK1521498. The
production of the P/NP and HAD rats was funded by the R24
Alcohol Research Resource Award grant (R24 AA015512)
from NIAAA. Charles R Goodlett was funded by a grant from
the IUPUI International Development Fund that supported
his sabbatical leave at the University of Cambridge. Maria
Pilar Garcia-Pardo was funded by Val+id para investigadores
en formación (Conselleria de educacion, Generalitat Valenci-
ana) that also supported her stay at the University of
Cambridge (January–April 2014) as a visiting student. With
this paper we would like to commemorate Daina Econo-
midou who died in December 2012 after a heroic fight against
lung cancer. The best way to remember her is to share with
the scientific community her dedication and enthusiastic
contribution to science through the data collected until a few
months before her death, including the data in Figure 1. We
thank Dr Larry Lumeng, Dr Richard Bell, and Rebecca Jane
Smith at the Indiana University School of Medicine for
facilitating the provision of the selected lines of rats; Dr Adam
Mar for writing the program to analyze the EPM data; Dr
Yolanda Peña-Oliver for analyzing the EPM data; Jing Xia for
analyzing the blood samples; Sam Miller for excellent statistical
advice; and Kristin Patterson and Ramprakash Govindarajan
for providing the GSK1521498 solutions.
REFERENCES
Arroyo M, Markou A, Robbins TW, Everitt BJ (1998). Acquisition,
maintenance and reinstatement of intravenous cocaine self-
administration under a second-order schedule of reinforcement
in rats: effects of conditioned cues and continuous access to
cocaine. Psychopharmacology (Berl) 140: 331–344.
Augier E, Flanigan M, Dulman RS, Pincus A, Schank JR, Rice KC
et al (2014). Wistar rats acquire and maintain self-administration
of 20% ethanol without water deprivation, saccharin/sucrose
fading, or extended access training. Psychopharmacology (Berl) 9:
114727.
Barker JM, Taylor JR (2014). Habitual alcohol seeking: modeling the
transition from casual drinking to addiction. Neurosci Biobehav
Rev 47: 281–294.
Carnicella S, Ron D, Barak S (2014). Intermittent ethanol access
schedule in rats as a preclinical model of alcohol abuse. Alcohol
48: 243–252.
Ciccocioppo R, Martin-Fardon R, Weiss F (2002). Effect of selective
blockade of mu(1) or delta opioid receptors on reinstatement of
alcohol-seeking behavior by drug-associated stimuli in rats.
Neuropsychopharmacology 27: 391–399.
Conklin CA, Robin N, Perkins KA, Salkeld RP, McClernon FJ
(2008). Proximal versus distal cues to smoke: the effects of
environments on smokers’ cue-reactivity. Exp Clin Psycho-
pharmacol 16: 207–214.
Czachowski CL, Delory MJ (2009). Acamprosate and naltrexone
treatment effects on ethanol and sucrose seeking and intake in
ethanol-dependent and nondependent rats. Psychopharmacology
(Berl) 204: 335–348.
Czachowski CL, Samson HH (1999). Breakpoint determination and
ethanol self-administration using an across-session progressive
ratio procedure in the rat. Alcohol Clin Exp Res 23: 1580–1586.
Czachowski CL, Samson HH (2002). Ethanol- and sucrose-
reinforced appetitive and consummatory responding in HAD1,
HAD2, and P rats. Alcohol Clin Exp Res 26: 1653–1661.
Davidson D, Amit Z (1997). Naltrexone blocks acquisition of
voluntary ethanol intake in rats. Alcohol Clin Exp Res 21:
677–683.
De Bruijn C, Korzec A, Koerselman F, van Den Brink W (2004).
Craving and withdrawal as core symptoms of alcohol depen-
dence. J Nerv Ment Dis 192: 494–502.
Dilleen R, Pelloux Y, Mar AC, Molander A, Robbins TW, Everitt BJ
et al (2012). High anxiety is a predisposing endophenotype for
loss of control over cocaine, but not heroin, self-administration
in rats. Psychopharmacology (Berl) 222: 89–97.
Drobes DJ, Anton RF, Thomas SE, Voronin K (2003). A clinical
laboratory paradigm for evaluating medication effects on alcohol
consumption: naltrexone and nalmefene. Neuropsychopharmacology
28: 755–764.
Economidou D, Dalley JW, Everitt BJ (2011). Selective norepinephrine
reuptake inhibition by atomoxetine prevents cue-induced heroin
and cocaine seeking. Biol Psychiatry 69: 266–274.
Everitt BJ (1990). Sexual motivation: a neural and behavioural
analysis of the mechanisms underlying appetitive and copulatory
responses of male rats. Neurosci Biobehav Rev 14: 217–232.
Everitt BJ, Robbins TW (2000). Second-order schedules of drug
reinforcement in rats and monkeys: measurement of reinforcing
efficacy and drug-seeking behaviour. Psychopharmacology (Berl)
153: 17–30.
Field M, Duka T (2002). Cues paired with a low dose of alcohol
acquire conditioned incentive properties in social drinkers.
Psychopharmacology (Berl) 159: 325–334.
Froehlich JC, Harts J, Lumeng L, Li TK (1988). Differences in
response to the aversive properties of ethanol in rats selectively
bred for oral ethanol preference. Pharmacol Biochem Behav 31:
215–222.
Froehlich JC, Harts J, Lumeng L, Li TK (1990). Naloxone attenuates
voluntary ethanol intake in rats selectively bred for high ethanol
preference. Pharmacol Biochem Behav 35: 385–390.
Gipson CD, Kupchik YM, Shen H, Reissner KJ, Thomas CA,
Kalivas PW (2013). Relapse induced by cues predicting cocaine
depends on rapid, transient synaptic potentiation. Neuron 77:
867–872.
Giuliano C, Robbins TW, Nathan PJ, Bullmore ET, Everitt BJ
(2012). Inhibition of opioid transmission at the μ-opioid receptor
prevents both food seeking and binge-like eating. Neuropsycho-
pharmacology 37: 2643–2652.
Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everitt BJ (2013).
Attenuation of cocaine and heroin seeking by μ-opioid receptor
antagonism. Psychopharmacology (Berl) 227: 137–147.
Goldberg SR, Kelleher RT, Goldberg DM (1981). Fixed-ratio
responding under second-order schedules of food presentation
or cocaine injection. J Pharmacol Exp Ther 218: 271–281.
Goldberg SR, Spealman RD, Kelleher RT (1979). Enhancement
of drug-seeking behavior by environmental stimuli associated
with cocaine or morphine injections. Neuropharmacology 18:
1015–1017.
Gual A, Bruguera P, López-Pelayo H (2014). Nalmefene and its use
in alcohol dependence. Drugs Today (Barc) 50: 347–355.
Henderson-Redmond A, Czachowski C (2014). Effects of systemic
opioid receptor ligands on ethanol- and sucrose seeking and
drinking in alcohol-preferring (P) and Long Evans rats. Psycho-
pharmacology (Berl) 231: 4309–4321.
Cue-maintained alcohol seeking and μ-opioid receptors
C Giuliano et al
2991
Neuropsychopharmacology
Herz A (1997). Endogenous opioid systems and alcohol addiction.
Psychopharmacology (Berl) 129: 99–111.
Ignar DM, Goetz AS, Noble KN, Carballo LH, Stroup AE, Fisher JC
et al (2011). Regulation of ingestive behaviors in the rat by
GSK1521498, a novel micro-opioid receptor-selective inverse
agonist. J Pharmacol Exp Ther 339: 24–34.
Kaminski BJ, Goodwin AK, Wand G, Weerts EM (2008).
Dissociation of alcohol-seeking and consumption under a
chained schedule of oral alcohol reinforcement in baboons.
Alcohol Clin Exp Res 32: 1014–1022.
Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K et al
(2014). The opioid receptor pharmacology of GSK1521498
compared to other ligands with differential effects on compulsive
reward-related behaviours. Psychopharmacology (Berl) 232:
305–314.
Koob GF (2013). Theoretical frameworks and mechanistic aspects
of alcohol addiction: alcohol addiction as a reward deficit
disorder. Curr Top Behav Neurosci 13: 3–30.
Krishnan-Sarin S, Wand GS, Li X-W, Portoghese PS, Froehlich JC
(1998). Effect of mu opioid receptor blockade on alcohol intake in
rats bred for high alcohol drinking. Pharmacol Biochem Behav 59:
627–635.
Lee JLC, Milton AL, Everitt BJ (2006). Cue-induced cocaine seeking
and relapse are reduced by disruption of drug memory
reconsolidation. J Neurosci 26: 5881–5887.
Ludwig AM (1986). Pavlov’s “bells” and alcohol craving. Addict
Behav 11: 87–91.
Marchant NJ, Li X, Shaham Y (2013). Recent developments in
animal models of drug relapse. Curr Opin Neurobiol 23: 675–683.
McBride WJ, Rodd ZA, Bell RL, Lumeng L, Li T-K (2014). The
alcohol-preferring (P) and high-alcohol-drinking (HAD) rats–
animal models of alcoholism. Alcohol 48: 209–215.
Milton AL, Schramm MJW, Wawrzynski JR, Gore F, Oikonomou-
Mpegeti F, Wang NQ et al (2012). Antagonism at NMDA
receptors, but not β-adrenergic receptors, disrupts the reconso-
lidation of pavlovian conditioned approach and instrumental
transfer for ethanol-associated conditioned stimuli. Psycho-
pharmacology (Berl) 219: 751–761.
Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI,
Colby SM et al (1999). Naltrexone’s effect on cue-elicited craving
among alcoholics in treatment. Alcohol Clin Exp Res 23:
1386–1394.
Nathan PJ, O’Neill BV, Bush MA, Koch A, Tao WX, Maltby K et al
(2012). Opioid receptor modulation of hedonic taste prefe-
rence and food intake: a single-dose safety, pharmacokinetic,
and pharmacodynamic investigation with GSK1521498, a novel
μ-opioid receptor inverse agonist. J Clin Pharmacol 52: 464–474.
National Council on Alcoholism and Drug Dependence. Welcome
to NCADD, at ohttp://ncadd.org/index.php4.
Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedraza M,
Abrams DB (1988). Relevance of cue reactivity to understanding
alcohol and smoking relapse. J Abnorm Psychol 97: 133–152.
Nowak KL, Ingraham CM, Mckinzie DL, Mcbride WJ, Lumeng L,
Li TK et al (2000). An assessment of novelty-seeking behavior in
alcohol-preferring and nonpreferring rats. Pharmacol Biochem
Behav 66: 113–121.
Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE,
Solinas M et al (2004). Human cocaine-seeking behavior and its
control by drug-associated stimuli in the laboratory. Neuro-
psychopharmacology 30: 433–443.
Rodd ZA, Bell RL, Sable HJK, Murphy JM, McBride WJ (2004).
Recent advances in animal models of alcohol craving and relapse.
Pharmacol Biochem Behav 79: 439–450.
Rohsenow DJ, Monti PM, Hutchison KE, Swift RM,
Colby SM, Kaplan GB (2000). Naltrexone’s effects on reactivity
to alcohol cues among alcoholic men. J Abnorm Psychol 109:
738–742.
Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M,
Soyka M (2010). Opioid antagonists for alcohol dependence.
Cochrane Database Syst Rev (12): CD001867.
Samson HH (1986). Initiation of ethanol reinforcement using a
sucrose-substitution procedure in food- and water-sated rats.
Alcohol Clin Exp Res 10: 436–442.
Samson HH, Chappell A, Czachowski C, Sharpe A (2001).
Measuring ethanol-seeking behavior: the effect of using repeated
extinction trials. Alcohol 24: 205–209.
Samson HH, Sharpe AL, Denning C (1999). Initiation of
ethanol self-administration in the rat using sucrose substitution
in a sipper-tube procedure. Psychopharmacology (Berl) 147:
274–279.
Schindler CW, Katz JL, Goldberg SR (1988). The use of second-
order schedules to study the influence of environmental stimuli
on drug-seeking behavior. NIDA Res Monogr 84: 180–195.
Schneekloth TD, Biernacka JM, Hall-Flavin DK, Karpyak VM,
Frye MA, Loukianova LL et al (2012). Alcohol craving as a
predictor of relapse. Am J Addict Am Acad Psychiatr Alcohol
Addict 21: S20–S26.
Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ,
Wise R et al (2008). Intermittent access to 20% ethanol induces
high ethanol consumption in Long-Evans and Wistar rats.
Alcohol Clin Exp Res 32: 1816–1823.
Smith SG, Werner TE, Davis WM (1977). Alcohol-associated condi-
tioned reinforcement. Psychopharmacology (Berl) 53: 223–226.
Stewart RB, Gatto GJ, Lumeng L, Li TK, Murphy JM (1993).
Comparison of alcohol-preferring (P) and nonpreferring (NP)
rats on tests of anxiety and for the anxiolytic effects of ethanol.
Alcohol 10: 1–10.
Tomie A, Sharma N (2014). Pavlovian sign-tracking model of
alcohol abuse. Curr Drug Abuse Rev 6: 201–219.
Viglinskaya IV, Overstreet DH, Kashevskaya OP, Badishtov BA,
Kampov-Polevoy AB, Seredenin SB et al (1995). To drink
or not to drink: tests of anxiety and immobility in alcohol-
preferring and alcohol-nonpreferring rat strains. Physiol Behav
57: 937–941.
Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992).
Naltrexone in the treatment of alcohol dependence. Arch Gen
Psychiatry 49: 876–880.
Wise RA (1973). Voluntary ethanol intake in rats following
exposure to ethanol on various schedules. Psychopharmacologia
29: 203–210.
Ziauddeen H, Chamberlain SR, Nathan PJ, Koch A, Maltby K,
Bush M et al (2013a). Effects of the mu-opioid receptor antagonist
GSK1521498 on hedonic and consummatory eating behaviour:
a proof of mechanism study in binge-eating obese subjects.
Mol Psychiatry 18: 1287–1293.
Ziauddeen H, Nathan PJ, Dodds C, Maltby K, Miller SR,
Waterworth D et al (2013b). The effects of alcohol on the
pharmacokinetics and pharmacodynamics of the selective mu-
opioid receptor antagonist GSK1521498 in healthy subjects. J Clin
Pharmacol 53: 1078–1090.
Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)
Cue-maintained alcohol seeking and μ-opioid receptors
C Giuliano et al
2992
Neuropsychopharmacology
